Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-24

Clinical Trial Update: Asenapine for Bipolar Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of asenapine for bipolar depression sponsored by the University of Cincinnati has been terminated; the snippet does not report trial ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)

Snippet

Sponsor: University of Cincinnati | Conditions: Bipolar Depression | Phase 2 | Status: TERMINATED